Aid agencies must invest more in strengthening health systems and infrastructure to avoid many millions of people losing their lives to multidrug-resistant tuberculosis by 2050, a group of U.K. members of Parliament said on World Tuberculosis Day.
Their call to action is backed by senior figures in the pharmaceutical sector, who told Devex preventing a resurgent TB pandemic was not only dependent on drug development.
Research published this week by the U.K. All Party Parliamentary Group on Global TB claims 75 million people could lose their lives to MDR-TB over the next 35 years and cost the global economy $16.7 trillion.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Gabriella Jóźwiak@GabriellaJ
Gabriella Jóźwiak is an award-winning journalist based in London. Her work on issues and policies affecting children and young people in developing countries and the U.K. has been published in national newspapers and magazines. Having worked in-house for domestic and international development charities, Jóźwiak has a keen interest in organizational development, and has worked as a journalist in several countries across West Africa and South America.
